XML 23 R12.htm IDEA: XBRL DOCUMENT v3.25.1
Accounts Payable and Accrued Expenses
 3 Months Ended
Mar. 31, 2025
Payables and Accruals [Abstract]  
Accounts Payable and Accrued Expenses

Note 4 – Accounts Payable and Accrued Expenses

 

Accounts payable and accrued expenses consisted of the following:

 

Schedule of Accounts Payable and Accrued Expenses

   March 31,
2025		  

December 31,

2024

 
Accounts payable  $158,483   $278,676 
Professional fees   103,590    40,271 
License fee   18,750    75,000 
Credit cards   2,108    2,536 
Total accounts payable and accrued expenses  $282,931   $396,483 

 

Accrued compensation of $1,407,658 and $1,415,093 as of March 31, 2025 and December 31, 2024, respectively, includes accrued salaries and health benefits to executives since inception and as well as board fees. Since inception, executive salaries have been paid in cash when the Company’s cash flow has permitted such payment. Prior to the IPO, in order to conserve cash, certain executives agreed to defer payments for compensation all of which was accrued. During December 2024, the Company returned to paying compensation to the executives upon the completion of the initial public offering. The Company will continue to make payments related to the accrued compensation if the Company has available cash to do so without otherwise negatively impacting the Company’s business plans.

 

 

JUPITER NEUROSCIENCES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2025